Judge Greenlights Aredia Cases Against Novartis
A federal judge has cleared the way for multidistrict litigation claiming that Novartis Pharmaceutical Corp.'s bone cancer drugs Aredia and Zometa cause a condition involving jaw deterioration, shooting down two of...To view the full article, register now.
Already a subscriber? Click here to view full article